APA
Treonze K. M., Alves K., Fischer P., Hagmann W. K., Hora D., Kulick A., Vakerich K., Smith N. D., Lingham R. B., Maniar S., Reger T. S., Zunic J., Munoz B., Prasit P., Nicholson D., Si Q., Judd K., Nicolich S., Kellerhouse P., Thompson D. & Mumford R. A. (20091102). Characterization of alpha(4)beta(1) (CD49d/CD29) on equine leukocytes: potential utility of a potent alpha(4)beta(1) (CD49d/CD29) receptor antagonist in the treatment of equine heaves (recurrent airway obstruction). : Veterinary immunology and immunopathology.
Chicago
Treonze Kelly M, Alves Kenneth, Fischer Paul, Hagmann William K, Hora Donald, Kulick Alison, Vakerich Ken, Smith Nicholas D, Lingham Russell B, Maniar Salony, Reger Thomas S, Zunic Jasmine, Munoz Benito, Prasit Peppi, Nicholson Donald, Si Qian, Judd Keith, Nicolich Susan, Kellerhouse Patricia, Thompson Donald and Mumford Richard A. 20091102. Characterization of alpha(4)beta(1) (CD49d/CD29) on equine leukocytes: potential utility of a potent alpha(4)beta(1) (CD49d/CD29) receptor antagonist in the treatment of equine heaves (recurrent airway obstruction). : Veterinary immunology and immunopathology.
Harvard
Treonze K. M., Alves K., Fischer P., Hagmann W. K., Hora D., Kulick A., Vakerich K., Smith N. D., Lingham R. B., Maniar S., Reger T. S., Zunic J., Munoz B., Prasit P., Nicholson D., Si Q., Judd K., Nicolich S., Kellerhouse P., Thompson D. and Mumford R. A. (20091102). Characterization of alpha(4)beta(1) (CD49d/CD29) on equine leukocytes: potential utility of a potent alpha(4)beta(1) (CD49d/CD29) receptor antagonist in the treatment of equine heaves (recurrent airway obstruction). : Veterinary immunology and immunopathology.
MLA
Treonze Kelly M, Alves Kenneth, Fischer Paul, Hagmann William K, Hora Donald, Kulick Alison, Vakerich Ken, Smith Nicholas D, Lingham Russell B, Maniar Salony, Reger Thomas S, Zunic Jasmine, Munoz Benito, Prasit Peppi, Nicholson Donald, Si Qian, Judd Keith, Nicolich Susan, Kellerhouse Patricia, Thompson Donald and Mumford Richard A. Characterization of alpha(4)beta(1) (CD49d/CD29) on equine leukocytes: potential utility of a potent alpha(4)beta(1) (CD49d/CD29) receptor antagonist in the treatment of equine heaves (recurrent airway obstruction). : Veterinary immunology and immunopathology. 20091102.